-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
September 15, 2005 - using estrogen
Tamoxifen, 3573;
placebo, 3566
50
Total
69
101
0.68 (0.50-0.92)
VTE … using estrogen
Tamoxifen, 6576;
placebo, 6599
55
Total
124
244
0.51 (0.41-0.63) **
VTE … using estrogen
Tamoxifen, 1238;
placebo, 1233
70
Total
34
36
0.94 (0.59-1.49) **
VTE … using estrogen
Tamoxifen, 2700;
placebo, 2708
46
Total
19
22
0.87 (0.47-1.60) **
VTE … estrogen receptor; NA = not available; NS = not statistically significant; PE = pulmonary embolism; VTE
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-screening-1996
January 01, 1996 - endometrium, and ovary), and with other disorders such as cholelithiasis, obstructive sleep apnea, venous … thromboembolism, and osteoarthritis. 8 , 20 , 37 Finally, obesity can affect the quality of life by
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
September 01, 2005 - estrogen receptor; NA � not available; NS � not statistically significant; PE � pulmonary embolism; VTE … Table 5—Continued
Adverse Effects
Type Treatment
Group, n
Placebo
Group,
n
Relative Risk
(95% CI)
VTE … 11 1.18 (0.53–2.63)†
Endometrial cancer 11 5 2.2 (0.86–6.06)
All-cause death 25 11 2.27 (1.12–4.60)†
VTE … 1.59 (0.93–2.77)†
Endometrial cancer 36 15 2.53 (1.35–4.97)
All-cause death 57 71 0.81 (0.56–1.16)†
VTE … 0.50–8.01)†
Stroke 9 5 1.81 (0.61–5.38)†
Endometrial cancer NA
All-cause death 6 9 0.67 (0.24–1.88)†
VTE
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-calcium-or-combined-supplementation-for-the-primary-prevention-of-fractures-in-adults-preventive-medication
April 17, 2018 - supplementation and found no significant increase in myocardial infarction, coronary heart disease, stroke, venous … thromboembolism, deep vein thrombosis, pulmonary embolism, or hospitalizations for heart failure; ARDs
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6fMLEz4CfAVoj9YBYVbm73
April 17, 2018 - supplementation and found no signifi-
cant increase in myocardial infarction, coronary heart disease, stroke,
venous … thromboembolism, deep vein thrombosis, pulmonary em-
bolism, or hospitalizations for heart failure;
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-depression-suicide-risk-adults
June 20, 2023 - Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zk8YxjaQxLGUTtt__nBQB_
September 09, 2021 - Depression,
antidepressant use, and risk of venous
thromboembolism: systematic review and
meta-analysis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
May 06, 2022 - Effect of low-dose aspirin on the occurrence of
venous thromboembolism: a randomized trial.